Medco Spinoff Plan Revised; PBM Margins Look Healthier In 2003
Executive Summary
The one-year delay in Merck's Medco spinoff means that the pharmacy benefit manager will begin operations as a separately traded public company with a healthier gross margin
You may also be interested in...
Medco Is Meeting Merck Market Share Targets; Spin-Off Plan Moves Ahead
Merck's market share within the Medco customer base is running about 33% higher than the company's overall national market share
Medco Is Meeting Merck Market Share Targets; Spin-Off Plan Moves Ahead
Merck's market share within the Medco customer base is running about 33% higher than the company's overall national market share
Medco Lets Snow Reign: CEO David Snow Joins PBM From WellChoice
Medco Health's separation from Merck will be overseen by former WellChoice Chief Operating Officer David Snow